Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Kashiwa, Chiba, Japan
View Trial Details
Recruiting

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

NCT07416474

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Affiliated to Chongqing University Chongqing, Chongqing Municipality, China
  • Chongqing Medical University First Affiliated Hospital Chongqing, Chongqing Municipality, China
View all 78 locations
View Trial Details
Recruiting

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

NCT06706076

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Arizona Phoenix, Arizona, United States
  • The Regents of the University of California - Irvine, CA Campus Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 42 locations
View Trial Details
Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

NCT06692738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 312 locations
View Trial Details
Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

NCT06686771

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Saint Mary's Hospital and Regional Medical Center Grand Junction, Colorado, United States
View all 75 locations
View Trial Details
Recruiting

A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

NCT07699328

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia
  • Monash Medical Centre Clayton Clayton, Victoria, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • AP-HM Hôpital Nord Marseille, Bouches-du-Rhône, France
View all 29 locations
View Trial Details

Related conditions